Candel Therapeutics (CADL) Short term Debt (2020 - 2023)
Historic Short term Debt for Candel Therapeutics (CADL) over the last 2 years, with Q3 2023 value amounting to $6.1 million.
- Candel Therapeutics' Short term Debt changed N/A to $6.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $463000.0 for FY2020, which is N/A changed from last year.
- Per Candel Therapeutics' latest filing, its Short term Debt stood at $6.1 million for Q3 2023.
- Candel Therapeutics' Short term Debt's 5-year high stood at $6.1 million during Q3 2023, with a 5-year trough of $463000.0 in Q4 2020.